Related Experiment Videos
[Surgical therapy of acute myocardial infarction]
Insights
Acute myocardial infarction therapy focuses on saving viable heart cells. Combining fibrinolysis with acute coronary surgery offers a hopeful new approach for high-risk patients.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Current acute myocardial infarction (AMI) therapy aims to preserve ischemic but viable myocardium.
- Acute coronary surgery is employed in 3.5% of coronary surgery patients (41 individuals) for AMI.
Purpose of the Study:
- To evaluate the effectiveness of acute coronary surgery, particularly in combination with fibrinolysis, for treating AMI.
- To assess the outcomes of patients undergoing acute coronary surgery for specific indications.
Main Methods:
- Retrospective analysis of 41 patients undergoing acute coronary surgery.
- Identification of preferred indications for acute coronary surgery, including post-coronary dilation vessel occlusion and post-fibrinolysis conditions.
- Analysis of hospital lethality in a subgroup of 22 patients treated with combined fibrinolysis and acute coronary surgery.
Main Results:
- Acute coronary surgery was performed on 41 patients.
- Preferred indications included post-dilation vessel occlusion and post-fibrinolysis states.
- Hospital lethality was 4.5% in the 22 patients who received combined fibrinolysis and acute coronary surgery.
Conclusions:
- Acute coronary surgery is a viable option for specific AMI patient groups.
- The combination of fibrinolysis and acute coronary surgery represents a promising advancement in AMI treatment.
- This active approach offers hope for improving outcomes in critically ill myocardial infarction patients.
Abstract:
All over the world the therapy of acute myocardial infarction has concentrated upon saving the ischaemically injured, but still viable cells of the myocardium. Also the acute coronary surgery, which among our groups of coronary-surgical patients has a proportion of 3.5% with 41 patients, answers this purpose. The preferred indication groups for acute coronary-surgical operations are the occlusion of the vessel after coronary dilation and the condition after intracoronary fibrinolysis. In these 22 patients the hospital lethality was only 4.5%. The reasonable active approach in acute myocardial infarction, particularly the combination fibrinolysis - acute coronary surgery, is a hopeful enlargement of the previous therapy for the highly imperilled patients with myocardial infarction.